Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Sara Freeman

News

Topical ivermectin study sheds light on dysbiosis in rosacea

Author:
Sara Freeman
Publish date: November 8, 2023

Research over the past decade has also started to look at the potential role of the skin microbiome in the disease process, but answers have...

  • Read More

News

More phase 3 data support use of nemolizumab for prurigo nodularis

Author:
Sara Freeman
Publish date: November 2, 2023

"Now I hope you understand why we are so excited," said lead investigator Sonja Ständer, MD.

  • Read More

News

Birch bark–derived treatment reduces daily dressings in patients with epidermolysis bullosa

Author:
Sara Freeman
Publish date: November 2, 2023

Despite being approved in Europe, Oleogel-S10 has not yet been approved to treat EB in the United States.

  • Read More

News

Roflumilast side effect benefits patients with psoriasis and overweight/obesity

Author:
Sara Freeman
Publish date: October 16, 2023

An “extraordinary” finding was how some patients’ weight status based on their BMI changed throughout the study.

  • Read More

News

Topical botanical drug coacillium curbs childhood alopecia

Author:
Sara Freeman
Publish date: October 16, 2023

Coacillium cutaneous solution is also under investigation as a treatment for persistent chemotherapy-induced alopecia, atopic dermatitis, and...

  • Read More

News

Axial spondyloarthritis: Does visibility with x-rays make a difference in management?

Author:
Sara Freeman
Publish date: August 15, 2023

“Axial spondyloarthritis is one disease, and whether it is radiographic or nonradiographic makes zero difference in the management of the patient...

  • Read More

News

Diagnosing chronic back pain: When to suspect axial spondyloarthritis

Author:
Sara Freeman
Publish date: August 14, 2023

Worldwide, the average time to diagnosis was found to be up to 6 years, but patient advocacy groups say the delay can be up to 10 years or more....

  • Read More

News

Enthesitis, arthritis, tenosynovitis linked to dupilumab use for atopic dermatitis

Author:
Sara Freeman
Publish date: June 1, 2023

Musculoskeletal symptoms identified in some patients treated with dupilumab for atopic dermatitis could help further understanding of how...

  • Read More

News

Low disease state for childhood lupus approaches validation

Author:
Sara Freeman
Publish date: May 10, 2023

A new childhood version of the Lupus Low Disease Activity State has been purposefully developed to align with the criteria already used for adults...

  • Read More

News

Normal CRP during RA flares: An ‘underappreciated, persistent phenotype’

Author:
Sara Freeman
Publish date: May 5, 2023

In about 5% of patients with seropositive RA, C-reactive protein levels were normal despite disease flares during a 5-year period. The findings...

  • Read More

News

Long-COVID rate may be higher with rheumatic diseases

Author:
Sara Freeman
Publish date: May 2, 2023

The results highlight the need for close monitoring and optimized multidisciplinary care for long-term adverse events after COVID-19 in patients...

  • Read More

News

NSAID use may mask MRI findings in a quarter of spondyloarthritis cases

Author:
Sara Freeman
Publish date: April 28, 2023

Among nearly one in four patients whose MRI results were initially positive for sacroiliitis, results were negative 6 weeks after NSAIDs were...

  • Read More

News

Meta-analysis examines cancer risk concern for JAK inhibitors

Author:
Sara Freeman
Publish date: April 26, 2023

Although no increased cancer risk was seen vs. methotrexate or placebo, Janus kinase inhibitors were associated with a higher cancer risk than...

  • Read More

News

Registry data ‘reassure’ on biologics’ heart attack risk in rheumatoid arthritis

Author:
Sara Freeman
Publish date: April 25, 2023

There is no difference in the risk of myocardial infarction with interleukin-6 (IL-6) vs. anti–tumor necrosis factor (TNF) therapy for rheumatoid...

  • Read More

News

Cardiovascular risk score multipliers suggested for rheumatic diseases

Author:
Sara Freeman
Publish date: December 21, 2022

Guidelines could tailor cardiovascular risk scores by using a multiplier of 2.5 for systemic sclerosis, 2.0 for lupus, and 1.5 for any other...

  • Read More

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Close